Search & Analyze
Popular Searches
Astrazeneca Pharma India Ltd.
Healthcare₹8,000.002.12%
24 Jul, 4:01 PM
CMP₹8,000.00
Mkt Cap₹19.68K Cr
P/E104.97
P/B22.72
ROE23.02%
52W High₹9,850.00
52W Low₹7,630.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
104.97
P/B Ratio
22.72
EV/EBITDA
66.21
Price/Sales
8.65
Dividend Yield (%)
0.46
EPS (TTM ₹)
75.01
Book Value (₹)
346.51
ROE (%)
23.02
ROCE (%)
31.24
ROA (%)
8.90
EBITDA Margin (%)
11.48
Net Profit Margin (%)
8.22
Debt/Equity
0.00
Current Ratio
1.68
Interest Coverage
57.17
Asset Turnover
1.08
Working Capital/Sales
3.04
Core EBITDA Growth (%)
-1.38
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 8056 | 10029.7 | 12955.3 | 17162.9 | 22755.8 |
| Net Sales | 8056 | 10029.7 | 12955.3 | 17162.9 | 22755.8 |
| Total Income | 8203.6 | 10290.7 | 13303.3 | 17569.2 | 23040.7 |
| Total Expenditure | 7194.2 | 8378.5 | 11110.8 | 14623.2 | 20135.5 |
| Operating Profit | 1009.4 | 1912.2 | 2192.5 | 2946 | 2905.2 |
| Depreciation | 169.5 | 162.6 | 149.4 | 399.9 | 285.8 |
| Exceptional Items | — | -402.3 | 164.3 | -967.9 | -52.5 |
| Profit Before Tax | 830.4 | 1341 | 2195.4 | 1563.6 | 2522 |
| Tax | 214.4 | 348.1 | 580.3 | 406.2 | 646.8 |
| Profit After Tax (PAT) | 616 | 992.9 | 1615.1 | 1157.4 | 1875.2 |
| EPS (₹) | 24.6 | 39.7 | 64.6 | 46.3 | 75.01 |
| Dividend Payout % | 500 | 800 | 1200 | 1600 | 1800 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 50 | 50 | 50 | 50 | 50 |
| Reserves | 5044.4 | 5811.2 | 7036.3 | 7582 | 8612.8 |
| Shareholders Funds | 5113.9 | 5886.9 | 7119.2 | 7703.5 | 8727.9 |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 9773.2 | 11420.8 | 12769 | 18376.3 | 23767.8 |
| Total Assets | 9773.2 | 11420.8 | 12769 | 18376.3 | 23767.8 |
| Book Value / Share | 203.776 | 234.448 | 283.452 | 305.28 | 346.512 |
| Assets | 9773.2 | 11420.8 | 12769 | 18376.3 | 23767.8 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 1008 | 582.9 | 278.7 | 653.6 | -151.4 |
| Investing Activities | 47.4 | 181.1 | 217.4 | 308 | 186.9 |
| Financing Activities | -94.6 | -244.8 | -443.8 | -655.9 | -919.7 |
| Net Cash Flow | 960.8 | 519.2 | 52.3 | 305.7 | -884.2 |
ASTRAZEN
₹8,000.00
+2.12%